These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31032141)

  • 1.
    Zhang DF; Fan Y; Xu M; Wang G; Wang D; Li J; Kong LL; Zhou H; Luo R; Bi R; Wu Y; Li GD; ; Li M; Luo XJ; Jiang HY; Tan L; Zhong C; Fang Y; Zhang C; Sheng N; Jiang T; Yao YG
    Natl Sci Rev; 2019 Mar; 6(2):257-274. PubMed ID: 31032141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The complement C7 variant rs3792646 is associated with amyotrophic lateral sclerosis in a Han Chinese population.
    He J; Fu J; Fan D
    Neurobiol Aging; 2021 Mar; 99():103.e1-103.e7. PubMed ID: 33303220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pilot whole-exome sequencing of a German early-onset Alzheimer's disease cohort reveals a substantial frequency of PSEN2 variants.
    Blauwendraat C; Wilke C; Jansen IE; Schulte C; Simón-Sánchez J; Metzger FG; Bender B; Gasser T; Maetzler W; Rizzu P; Heutink P; Synofzik M
    Neurobiol Aging; 2016 Jan; 37():208.e11-208.e17. PubMed ID: 26522186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Pathogenic Variant p.Phe177Val in
    Jiang B; Bi M; Li J; Liu Q; Xiao NA; Fang J; Shi MY; Yu ZW; Ma QL; Tong SJ; Zheng KM
    Front Genet; 2020; 11():713. PubMed ID: 32754199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knowledge-driven binning approach for rare variant association analysis: application to neuroimaging biomarkers in Alzheimer's disease.
    Kim D; Basile AO; Bang L; Horgusluoglu E; Lee S; Ritchie MD; Saykin AJ; Nho K
    BMC Med Inform Decis Mak; 2017 May; 17(Suppl 1):61. PubMed ID: 28539126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in ABCA7 in a Belgian cohort of Alzheimer's disease patients: a targeted resequencing study.
    Cuyvers E; De Roeck A; Van den Bossche T; Van Cauwenberghe C; Bettens K; Vermeulen S; Mattheijssens M; Peeters K; Engelborghs S; Vandenbulcke M; Vandenberghe R; De Deyn PP; Van Broeckhoven C; Sleegers K
    Lancet Neurol; 2015 Aug; 14(8):814-822. PubMed ID: 26141617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic association of urokinase-type plasminogen activator gene rs2227564 site polymorphism with sporadic Alzheimer's disease in the Han Chinese population.
    Ji X; Jia L; Jia J; Qi L
    Neural Regen Res; 2012 Oct; 7(30):2377-83. PubMed ID: 25538763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
    Karikari TK; Pascoal TA; Ashton NJ; Janelidze S; Benedet AL; Rodriguez JL; Chamoun M; Savard M; Kang MS; Therriault J; Schöll M; Massarweh G; Soucy JP; Höglund K; Brinkmalm G; Mattsson N; Palmqvist S; Gauthier S; Stomrud E; Zetterberg H; Hansson O; Rosa-Neto P; Blennow K
    Lancet Neurol; 2020 May; 19(5):422-433. PubMed ID: 32333900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An exploratory study of the association between SORL1 polymorphisms and sporadic Alzheimer's disease in the Han Chinese population.
    Zhang F; Liu X; Wang B; Cheng Z; Zhao X; Zhu J; Wang D; Wang Y; Dong A; Li P; Jin C
    Neuropsychiatr Dis Treat; 2015; 11():1443-8. PubMed ID: 26109858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration of bioinformatics and imaging informatics for identifying rare PSEN1 variants in Alzheimer's disease.
    Nho K; Horgusluoglu E; Kim S; Risacher SL; Kim D; Foroud T; Aisen PS; Petersen RC; Jack CR; Shaw LM; Trojanowski JQ; Weiner MW; Green RC; Toga AW; Saykin AJ;
    BMC Med Genomics; 2016 Aug; 9 Suppl 1(Suppl 1):30. PubMed ID: 27535542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association analysis of rare variants near the APOE region with CSF and neuroimaging biomarkers of Alzheimer's disease.
    Nho K; Kim S; Horgusluoglu E; Risacher SL; Shen L; Kim D; Lee S; Foroud T; Shaw LM; Trojanowski JQ; Aisen PS; Petersen RC; Jack CR; Weiner MW; Green RC; Toga AW; Saykin AJ;
    BMC Med Genomics; 2017 May; 10(Suppl 1):29. PubMed ID: 28589856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of the CR1 polymorphism with late-onset Alzheimer's disease in Chinese Han populations: a meta-analysis.
    Jin C; Li W; Yuan J; Xu W; Cheng Z
    Neurosci Lett; 2012 Oct; 527(1):46-9. PubMed ID: 22960360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smoking and Alzheimer's disease among Mongolian and Han Chinese aged 55 years and over living in the Inner Mongolia farming area of China.
    Zhang C; Da L; Zhao S; Wang D; Niu G; Huriletemuer
    Neural Regen Res; 2012 Jul; 7(20):1570-7. PubMed ID: 25657695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin receptor type 1A gene linked to Alzheimer's disease in old age.
    Sulkava S; Muggalla P; Sulkava R; Ollila HM; Peuralinna T; Myllykangas L; Kaivola K; Stone DJ; Traynor BJ; Renton AE; Rivera AM; Helisalmi S; Soininen H; Polvikoski T; Hiltunen M; Tienari PJ; Huttunen HJ; Paunio T
    Sleep; 2018 Jul; 41(7):. PubMed ID: 29982836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SORL1 rare variants: a major risk factor for familial early-onset Alzheimer's disease.
    Nicolas G; Charbonnier C; Wallon D; Quenez O; Bellenguez C; Grenier-Boley B; Rousseau S; Richard AC; Rovelet-Lecrux A; Le Guennec K; Bacq D; Garnier JG; Olaso R; Boland A; Meyer V; Deleuze JF; Amouyel P; Munter HM; Bourque G; Lathrop M; Frebourg T; Redon R; Letenneur L; Dartigues JF; Génin E; Lambert JC; Hannequin D; Campion D;
    Mol Psychiatry; 2016 Jun; 21(6):831-6. PubMed ID: 26303663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
    Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
    Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First effects of rising amyloid-β in transgenic mouse brain: synaptic transmission and gene expression.
    Cummings DM; Liu W; Portelius E; Bayram S; Yasvoina M; Ho SH; Smits H; Ali SS; Steinberg R; Pegasiou CM; James OT; Matarin M; Richardson JC; Zetterberg H; Blennow K; Hardy JA; Salih DA; Edwards FA
    Brain; 2015 Jul; 138(Pt 7):1992-2004. PubMed ID: 25981962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement receptor 1 polymorphisms and risk of late-onset Alzheimer's disease.
    Zhang Q; Yu JT; Zhu QX; Zhang W; Wu ZC; Miao D; Tan L
    Brain Res; 2010 Aug; 1348():216-21. PubMed ID: 20558149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presenilin E318G variant and Alzheimer's disease risk: the Cache County study.
    Hippen AA; Ebbert MT; Norton MC; Tschanz JT; Munger RG; Corcoran CD; Kauwe JS
    BMC Genomics; 2016 Jun; 17 Suppl 3(Suppl 3):438. PubMed ID: 27357204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of LRRTM3 polymorphisms with late-onset Alzheimer's disease in Han Chinese.
    Wang J; Yu JT; Jiang T; Tan MS; Wang HF; Tan L; Hu N; Sun L; Zhang W; Tan L
    Exp Gerontol; 2014 Apr; 52():18-22. PubMed ID: 24463050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.